In this review, we summarize the latest findings on TP73-AS1 expression in human cancers, its molecular mechanisms, and clinical significance, with a particular focus on its potential as a diagnostic biomarker and therapeutic target, as well as the association between its single nucleotide polymorphisms (SNPs) and cancer susceptibility. The gene discussed is TP73; the disease is cancer.